Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ershiwuwei Feibing Wan is a traditional Tibetan medicine (TTM) developed and manufactured by Xizang Ganlu Tibetan Medicine. Formulated as an oral pill, it consists of 25 distinct ingredients, including various herbs and minerals, according to traditional Tibetan pharmacological principles. It is primarily indicated for the treatment of various respiratory conditions, collectively referred to as lung diseases, such as chronic bronchitis, asthma, and pulmonary infections. The therapeutic action of the formulation is traditionally described as clearing heat, detoxifying the lungs, and alleviating cough and phlegm. It is an approved pharmaceutical product in China, holding the National Drug License Number Z54020028.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ershiwuwei Feibing Wan.